文献速递中毒与环境急症重症综合管理与镇静镇痛

血液灌流联合连续性静脉-静脉血液滤过治疗百草枯中毒的临床效果:一项Meta分析

[Clinical effect of haemoperfusion combined with continuous veno-veno haemofiltration in treatment of paraquat poisoning: a Meta-analysis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论Meta分析显示,与单用血液灌流相比,血液灌流联合连续性静脉-静脉血液滤过可降低百草枯中毒患者病死率(OR=0.55)并延长暴露至死亡时间。

该Meta分析检索万方、CNKI、CBM、维普、PubMed、Embase、Cochrane Library建库至2018年7月的中英文文献,纳入20篇文献(6项随机对照试验、14项病例对照研究),共2 870例百草枯中毒患者,对照组1 558例单用血液灌流,实验组1 312例血液灌流联合连续性静脉-静脉血液滤过。结果显示实验组病死率显著低于对照组(OR=0.55,95%CI 0.42~0.73,P<0.000 1),暴露至死亡时间显著延长(SMD=2.16,95%CI 1.46~2.86,P<0.000 01),治疗期间血肌酐峰值(SMD=-0.53,95%CI -0.65~-0.42)和丙氨酸氨基转移酶峰值(SMD=-0.72,95%CI -0.99~-0.44)均显著降低,治疗第7天动脉血氧分压显著高于对照组(SMD=0.23,95%CI 0.29~0.98,P=0.000 3)。实验组循环衰竭发生率显著低于对照组(OR=0.26,95%CI 0.19~0.37),但呼吸衰竭发生率显著高于对照组(OR=4.14,95%CI 3.00~5.72)。

要点

  • 与单用血液灌流相比,血液灌流联合连续性静脉-静脉血液滤过使百草枯中毒患者病死率降低(OR=0.55,95%CI 0.42~0.73,P<0.000 1)。
  • 联合治疗组暴露至死亡时间较单用血液灌流组显著延长(SMD=2.16,95%CI 1.46~2.86,P<0.000 01)。
  • 联合治疗组治疗期间血肌酐峰值(SMD=-0.53,95%CI -0.65~-0.42)和丙氨酸氨基转移酶峰值(SMD=-0.72,95%CI -0.99~-0.44)均显著低于对照组。
  • 联合治疗组循环衰竭发生率显著低于对照组(OR=0.26,95%CI 0.19~0.37),但呼吸衰竭发生率显著高于对照组(OR=4.14,95%CI 3.00~5.72,P<0.000 01)。
  • 治疗第3天两组动脉血氧分压无显著差异(SMD=0.15,95%CI -0.19~0.49,P=0.40),第7天联合治疗组显著高于对照组(SMD=0.23,95%CI 0.29~0.98,P=0.000 3)。

适用人群与场景

  • 急性百草枯中毒患者,纳入中英文文献中接受血液灌流联合连续性静脉-静脉血液滤过(实验组)或单用血液灌流(对照组)治疗者。

处置流程与药物剂量

  • 实验组采用血液灌流联合连续性静脉-静脉血液滤过治疗,对照组单用血液灌流治疗。

研究设计与关键结果

  • 最终纳入20篇文献(中文18篇、英文2篇),其中随机对照试验6项、病例对照研究14项,共2 870例患者,对照组1 558例、实验组1 312例。
  • 实验组病死率显著低于对照组(OR=0.55,95%CI 0.42~0.73,P<0.000 1)。
  • 实验组患者暴露至死亡时间显著长于对照组(SMD=2.16,95%CI 1.46~2.86,P<0.000 01)。
  • 治疗期间实验组血肌酐峰值显著低于对照组(SMD=-0.53,95%CI -0.65~-0.42,P<0.000 01),丙氨酸氨基转移酶峰值亦降低(SMD=-0.72,95%CI -0.99~-0.44,P<0.000 01)。
  • 治疗第3天两组动脉血氧分压无显著差异(SMD=0.15,95%CI -0.19~0.49,P=0.40),第7天实验组显著高于对照组(SMD=0.23,95%CI 0.29~0.98,P=0.000 3)。
  • 实验组循环衰竭发生率显著低于对照组(OR=0.26,95%CI 0.19~0.37,P<0.000 01),但呼吸衰竭发生率显著高于对照组(OR=4.14,95%CI 3.00~5.72,P<0.000 01)。
  • 敏感性分析排除了异质性对统计结果的影响,漏斗图提示病死率和死亡患者生存时间存在发表偏倚。

证据类型、等级与局限

  • 证据类型:Meta分析,纳入6项随机对照试验和14项病例对照研究,文献质量分别采用改良Jadad评分表或Newcastle-Ottawa量表(NOS)评价。
  • 局限:敏感性分析排除了异质性对统计结果的影响;漏斗图提示病死率和死亡患者生存时间存在发表偏倚。

对床旁实践的改变

  • 作者认为,与单用血液灌流相比,血液灌流联合连续性静脉-静脉血液滤过可更好地改善百草枯中毒患者的肝肾功能和氧合状态,降低早期循环衰竭发生率,延长生存时间并降低病死率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To systematically analyze the effect of haemoperfusion (HP) combined with continuous veno-veno haemofiltration (CVVH) in the treatment of the patients with paraquat poisoning (PQP).

METHODS: Words of paraquat, poisoning, continuous venous hemofiltration, hemoperfusion, hemodiafiltration in Chinese and paraquat, poisoning, intoxication, haemofiltration, continuous venovenous haemofiltration, haemoperfusion in English were chosen as keywords, the Chinese and English literatures about acute PQP treated with HP combined with CVVH published in Wanfang database, CNKI, CBM, VIP database, PubMed, Embase, Cochrane Library were searched by computer, and the retrieval time was from the establishment of the database to July 2018. The experimental group was treated with HP combined with CVVH, while the control group was treated with HP alone. Besides, the outcome indicators included mortality, survival time of dead patients (the patient's time from exposure to poison to death), serum creatinine (SCr), alanine aminotransferase (ALT), arterial partial pressure of oxygen (PaO2), and incidence of circulatory and respiratory failure. The literature data were extracted by two researchers independently, the quality of the literature was evaluated according to the modified Jadad score table or Newcastle-Ottawa scale (NOS), and the Meta-analysis was carried out by RevMan 5.3 software; and the stability of the results of Meta-analysis was tested by sensitivity analysis. Further, the publication bias was analyzed through drawing a funnel diagram.

RESULTS: Finally, 20 articles were included, with 18 in Chinese and 2 in English. Among them, 6 were randomized controlled trial (RCT) and 14 were case-control studies. Furthermore, a total of 2 870 patients were involved, with 1 558 in the control group and 1 312 in the experimental group. Meta-analysis showed that the mortality rate of patients in the experimental group was significantly lower than that in the control group [odds ratio (OR) = 0.55, 95% confidence interval (95%CI) = 0.42 to 0.73, P < 0.000 1], the patients' time from toxin exposure to death was significantly longer than that in the control group [standard mean difference (SMD) = 2.16, 95%CI = 1.46 to 2.86, P < 0.000 01). In the course of treatment, the peak value of SCr in the experimental group was significantly lower than that in the control group (SMD = -0.53, 95%CI = -0.65 to -0.42, P < 0.000 01), and the peak value of ALT was also decreased (SMD = -0.72, 95%CI = -0.99 to -0.44, P < 0.000 01). Besides, there was no significant difference in PaO2 between the two groups on the 3rd day of treatment (SMD = 0.15, 95%CI = -0.19-0.49, P = 0.40), but on the 7th day, PaO2 in the experimental group was significantly higher than that in the control group (SMD = 0.23, 95%CI = 0.29 to 0.98, P = 0.000 3). Furthermore, the incidence of circulatory failure in the experimental group was significantly lower than that in the control group (OR = 0.26, 95%CI = 0.19 to 0.37, P < 0.000 01), but the incidence of respiratory failure was significantly higher than that in the control group (OR = 4.14, 95%CI = 3.00 to 5.72, P < 0.000 01). The influence of heterogeneity on statistical results was excluded in the sensitivity analysis, and funnel plot diagram was applied to indicate the publication bias of mortality and survival time of the dead patients.

CONCLUSIONS: Combined with HP alone, HP combined with CVVH could better improve liver and kidney function and oxygenation state of PQP patients, reduce the incidence of early circulatory failure, prolong the survival time and reduce the death rate of PQP patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang Y, Wu Y, Shen F, et al. [Clinical effect of haemoperfusion combined with continuous veno-veno haemofiltration in treatment of paraquat poisoning: a Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30827312. doi:10.3760/cma.j.issn.2095-4352.2019.02.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。